GeneMatrix Inc (109820) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.027x

Based on the latest financial reports, GeneMatrix Inc (109820) has a cash flow conversion efficiency ratio of 0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩500.19 Million ≈ $338.97K USD) by net assets (₩18.32 Billion ≈ $12.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

GeneMatrix Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how GeneMatrix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GeneMatrix Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

GeneMatrix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GeneMatrix Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
VRX Silica Ltd AU:VRX	-0.090x
Seker Finansal Kiralama AS IS:SEKFK	0.281x
Old Market Capital Corporation NASDAQ:OMCC	-0.002x
Perdana Gapura Prima Tbk JK:GPRA	0.078x
Highest Performances Holdings Inc. NASDAQ:HPH	-0.004x
Kincora Copper Ltd V:KCC	-0.005x
BBC Co. Ltd. KQ:318410	0.013x
China Aoyuan Group Limited F:47C	-0.067x

Annual Cash Flow Conversion Efficiency for GeneMatrix Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of GeneMatrix Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of GeneMatrix Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩19.23 Billion ≈ $13.03 Million	₩-200.12 Million ≈ $-135.62K	-0.010x	+89.73%
2023-12-31	₩23.15 Billion ≈ $15.69 Million	₩-2.35 Billion ≈ $-1.59 Million	-0.101x	-139.49%
2022-12-31	₩24.19 Billion ≈ $16.39 Million	₩-1.02 Billion ≈ $-693.53K	-0.042x	-140.59%
2021-12-31	₩32.32 Billion ≈ $21.90 Million	₩3.37 Billion ≈ $2.28 Million	0.104x	-22.75%
2020-12-31	₩33.39 Billion ≈ $22.63 Million	₩4.51 Billion ≈ $3.05 Million	0.135x	+190.33%
2019-12-31	₩15.25 Billion ≈ $10.33 Million	₩-2.28 Billion ≈ $-1.54 Million	-0.149x	+40.89%
2018-12-31	₩10.83 Billion ≈ $7.34 Million	₩-2.74 Billion ≈ $-1.86 Million	-0.253x	-57.59%
2017-12-31	₩11.06 Billion ≈ $7.49 Million	₩-1.77 Billion ≈ $-1.20 Million	-0.160x	-436.38%
2016-12-31	₩12.48 Billion ≈ $8.46 Million	₩-373.25 Million ≈ $-252.95K	-0.030x	+49.30%
2015-12-31	₩10.04 Billion ≈ $6.80 Million	₩-591.96 Million ≈ $-401.17K	-0.059x	+49.01%
2014-12-31	₩11.89 Billion ≈ $8.06 Million	₩-1.38 Billion ≈ $-931.91K	-0.116x	--

About GeneMatrix Inc

KQ:109820 Korea Diagnostics & Research

Market Cap

$27.53 Million

₩40.63 Billion KRW

Market Cap Rank

#23988 Global

#1740 in Korea

Share Price

₩2035.00

Change (1 day)

+6.27%

52-Week Range

₩1899.00 - ₩3345.00

All Time High

₩33900.00